Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Vet Comp Oncol ; 9(2): 149-57, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21569200

RESUMEN

5-Lipoxygenase (5-LO) is overexpressed in human prostate carcinomas (PCs), and its inhibition decreases proliferation and induces apoptosis in prostate cancer cell lines. We hypothesized that 5-LO would be overexpressed in canine PC compared with benign prostate tissue and may be important in the pathogenesis of the disease. Immunoblot analysis of canine PC and benign prostatic hyperplasia (BPH) tissues demonstrated 5-LO expression in both. 5-LO immunohistochemical staining was not significantly different within the stromal or epithelial components of canine primary PC, BPH or suppurative prostatitis, suggesting that differential expression of this enzyme does not occur in these conditions. The percentage of tumour cells expressing 5-LO was significantly lower in metastatic PC lesions compared with primary PC (P < 0.0001). This decreased expression may indicate down-regulation or altered expression of the enzyme with progression of canine PC to a metastatic phenotype.


Asunto(s)
Araquidonato 5-Lipooxigenasa/metabolismo , Enfermedades de los Perros/enzimología , Hiperplasia Prostática/veterinaria , Neoplasias de la Próstata/veterinaria , Animales , Western Blotting/veterinaria , Enfermedades de los Perros/patología , Perros , Inmunohistoquímica/veterinaria , Masculino , Metástasis de la Neoplasia , Hiperplasia Prostática/enzimología , Neoplasias de la Próstata/enzimología , Neoplasias de la Próstata/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA